France
Blue Bees Therapeutics
Blue Bees Therapeutics develops Firs-in-Class immunotherapy to treat cancer.
The technology comes from CEA Paris-Saclay, it allows to generate immunomodulatory antibodies stimulating the anti-tumor immune response.
CREATION
EMPLOYEES
CITY
Orsay
DEVELOPMENT LEVEL
FUNDRAISING
FUNDRAISING AMOUNT
2M€